In the United States, about 20 people die every day waiting for an organ transplant. Patients sometimes wait years for a match. Many others, disproportionately those of color, never even get placed on ...

Scientists from Children’s Medical Research Institute (CMRI) have successfully tested adeno-associated viral vector-based (AAV) gene therapies in whole human livers in the lab. The study, which is ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...

WASHINGTON (AP) — The U.S. is developing new safeguards for the organ transplant system after a government investigation found a Kentucky group continued preparations for organ donation by some ...

New England Donor Services logged a record number of organ transplants in 2025, but is warning that federal changes could ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

A new study from Karolinska Institutet in Sweden reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholesterol that can otherwise cause damage to arteries. The ...

The connection between the human liver and the intestine is unique, and the “gut-liver axis” plays a vital role in regulating liver disease pathology. When homeostasis is disturbed, changes in dietary ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

Inequities in access to transplant are in part due to the nature and organization of the selection process. The limited organ supply and rising incidence of end-stage organ disease have resulted in a ...